InMed Pharmaceuticals (TSX:IN) Marketable Securities : C$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is InMed Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. InMed Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2023 was C$0.00 Mil.

InMed Pharmaceuticals's annual Marketable Securities increased from Jun. 2021 (C$0.06 Mil) to Jun. 2022 (C$0.06 Mil) but then declined from Jun. 2022 (C$0.06 Mil) to Jun. 2023 (C$0.00 Mil).

InMed Pharmaceuticals Marketable Securities Historical Data

The historical data trend for InMed Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Marketable Securities Chart

InMed Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Marketable Securities

Get a 7-Day Free Trial

5.23

0.06

InMed Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

InMed Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

InMed Pharmaceuticals (TSX:IN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

InMed Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals (TSX:IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (TSX:IN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

INM:USA MWG0:Germany

Address

815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (TSX:IN) Headlines

No Headlines